Tonelotto, V., Costa Garcia, M., O’Reilly, E., Smith, K. F., Slater, K., Dillon, E. T., . . . Kennedy, B. N. (2024). 1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature.
Citación estilo ChicagoTonelotto, Valentina, et al. 1,4-dihydroxy Quininib Activates Ferroptosis Pathways in Metastatic Uveal Melanoma and Reveals a Novel Prognostic Biomarker Signature. 2024.
Cita MLATonelotto, Valentina, et al. 1,4-dihydroxy Quininib Activates Ferroptosis Pathways in Metastatic Uveal Melanoma and Reveals a Novel Prognostic Biomarker Signature. 2024.
Precaución: Estas citas no son 100% exactas.